Andrew D. Dickinson

2019

In 2019, Andrew D. Dickinson earned a total compensation of $5.6M as Executive Vice President, Chief Financial Officer at Gilead Sciences.

Compensation breakdown

Bonus$1,000,000
Non-Equity Incentive Plan$1,086,800
Option Awards$1,000,096
Salary$802,308
Stock Awards$1,708,267
Other$12,000
Total$5,609,471

Dickinson received $1.7M in stock awards, accounting for 30% of the total pay in 2019.

Dickinson also received $1M in bonus, $1.1M in non-equity incentive plan, $1M in option awards, $802.3K in salary and $12K in other compensation.

Rankings

In 2019, Andrew D. Dickinson's compensation ranked 1,877th out of 13,971 executives tracked by ExecPay. In other words, Dickinson earned more than 86.6% of executives.

ClassificationRankingPercentile
All
1,877
out of 13,971
87th
Division
Manufacturing
672
out of 5,692
88th
Major group
Chemicals And Allied Products
206
out of 2,189
91st
Industry group
Drugs
164
out of 1,875
91st
Industry
Biological Products, Except Diagnostic Substances
39
out of 389
90th

Pay ratio

Andrew D. Dickinson's Pay$5,609,471
Median Employee's Pay$173,264
Pay Ratio

32

to 1

In 2019, the annual total compensation of Andrew D. Dickinson was $5,609,471.

The annual total compensation of the median employee at Gilead Sciences was $173,264.

The ratio of Andrew D. Dickinson's pay to the pay of median employee was therefore 32 to one.

Source: SEC filing on March 24, 2020.

Dickinson's colleagues

We found eight more compensation records of executives who worked with Andrew D. Dickinson at Gilead Sciences in 2019.

2019

Daniel O'Day

Gilead Sciences

Chief Executive Officer

2019

Johanna Mercier

Gilead Sciences

Chief Commercial Officer

2019

Gregg Alton

Gilead Sciences

Chief Executive Officer

2019

Laura Hamill

Gilead Sciences

Former Executive Vice President Worldwide Commercial Operations

2019

Robin Washington

Gilead Sciences

Chief Financial Officer

2019

John McHutchison

Gilead Sciences

Chief Scientific Officer

2019

Brett Pletcher

Gilead Sciences

General Counsel

2019

Merdad Parsey

Gilead Sciences

Chief Medical Officer

News

You may also like